MA32635B1 - Produit medicamenteux et traitement associe - Google Patents

Produit medicamenteux et traitement associe

Info

Publication number
MA32635B1
MA32635B1 MA33701A MA33701A MA32635B1 MA 32635 B1 MA32635 B1 MA 32635B1 MA 33701 A MA33701 A MA 33701A MA 33701 A MA33701 A MA 33701A MA 32635 B1 MA32635 B1 MA 32635B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical product
associated treatment
paracetamol
ibuprofen
approximately
Prior art date
Application number
MA33701A
Other languages
Arabic (ar)
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32635(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of MA32635B1 publication Critical patent/MA32635B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne l'utilisation de paracétamol et d'ibuprofène dans la préparation d'un médicament pour traiter l'ostéoarthrite ou la polyarthrite rhumatoïde. Ce médicament comprend une composition combinée constituée approximativement de 125 à 150 mg d'ibuprofène et approximativement de 475 mg à 500 mg de paracétamol.
MA33701A 2008-10-14 2011-03-14 Produit medicamenteux et traitement associe MA32635B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
PCT/NZ2009/000220 WO2010044681A1 (fr) 2008-10-14 2009-10-12 Produit médicamenteux et traitement associé

Publications (1)

Publication Number Publication Date
MA32635B1 true MA32635B1 (fr) 2011-09-01

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33701A MA32635B1 (fr) 2008-10-14 2011-03-14 Produit medicamenteux et traitement associe

Country Status (29)

Country Link
US (1) US20110166234A1 (fr)
EP (1) EP2341900B1 (fr)
JP (1) JP2012505830A (fr)
KR (1) KR20110112279A (fr)
CN (1) CN102215835A (fr)
AU (1) AU2009304002B9 (fr)
BR (1) BRPI0914086A2 (fr)
CA (1) CA2735834C (fr)
CH (1) CH702339B1 (fr)
CL (1) CL2011000678A1 (fr)
CO (1) CO6341553A2 (fr)
CY (1) CY1122198T1 (fr)
DK (1) DK2341900T3 (fr)
ES (1) ES2725151T3 (fr)
GB (1) GB2476418B (fr)
HR (1) HRP20190891T1 (fr)
HU (1) HUE043063T2 (fr)
LT (1) LT2341900T (fr)
MA (1) MA32635B1 (fr)
MX (1) MX340662B (fr)
MY (1) MY153932A (fr)
NZ (1) NZ591496A (fr)
PL (1) PL2341900T3 (fr)
PT (1) PT2341900T (fr)
RU (1) RU2487707C2 (fr)
SI (1) SI2341900T1 (fr)
TR (2) TR201102810T2 (fr)
WO (1) WO2010044681A1 (fr)
ZA (1) ZA201101752B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1781277T3 (pl) 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
MY160572A (en) 2010-11-04 2017-03-15 Aft Pharmaceuticals Ltd A combination composition
WO2016008546A1 (fr) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Formulation aqueuse comprenant du paracétamol et de l'ibuprofène
WO2018192664A1 (fr) 2017-04-20 2018-10-25 Hyloris Developments Sa Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci
JP7152481B2 (ja) * 2017-07-10 2022-10-12 ジェル キャップ テクノロジーズ，エルエルシー 二重放出カプセル剤形、ならびにそれを製造する方法、装置およびシステム
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (fr) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Composition pharmaceutique comprenant du naproxène et du paracétamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
EP0109281A1 (fr) * 1982-11-15 1984-05-23 The Upjohn Company Compositions contenant du flurbiprofen ou de l'ibuprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (fr) * 1989-08-23 1995-08-15 Thomas M. Tencza Mode de preparation de comprimes contenant de l'ibuprofene, de l'acetaminophere et de la cafeine, les produits ainsi obtenue et leurs applications
PL1781277T3 (pl) * 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
HRP20190891T1 (hr) 2019-07-12
MX2011003928A (es) 2011-08-12
RU2011111792A (ru) 2012-11-27
BRPI0914086A2 (pt) 2020-01-21
EP2341900B1 (fr) 2019-02-20
MX340662B (es) 2016-07-20
CH702339B1 (de) 2016-06-15
JP2012505830A (ja) 2012-03-08
CA2735834C (fr) 2017-05-16
GB201105249D0 (en) 2011-05-11
PT2341900T (pt) 2019-05-14
SI2341900T1 (sl) 2019-06-28
TR201102810T2 (tr) 2011-05-23
EP2341900A1 (fr) 2011-07-13
KR20110112279A (ko) 2011-10-12
ES2725151T3 (es) 2019-09-19
AU2009304002B9 (en) 2014-06-26
LT2341900T (lt) 2019-04-10
NZ591496A (en) 2012-12-21
US20110166234A1 (en) 2011-07-07
RU2487707C2 (ru) 2013-07-20
AU2009304002B2 (en) 2013-04-18
ZA201101752B (en) 2012-02-29
CA2735834A1 (fr) 2010-04-22
CO6341553A2 (es) 2011-11-21
GB2476418B (en) 2013-04-24
CN102215835A (zh) 2011-10-12
GB2476418A (en) 2011-06-22
WO2010044681A1 (fr) 2010-04-22
CY1122198T1 (el) 2020-11-25
MY153932A (en) 2015-04-15
AU2009304002A1 (en) 2010-04-22
TR201906742T4 (tr) 2019-05-21
EP2341900A4 (fr) 2012-02-29
PL2341900T3 (pl) 2019-08-30
CL2011000678A1 (es) 2011-09-23
HUE043063T2 (hu) 2019-07-29
DK2341900T3 (da) 2019-05-20

Similar Documents

Publication Publication Date Title
MA32635B1 (fr) Produit medicamenteux et traitement associe
MA34517B1 (fr) Promédicaments comprenant un conjugué exendine-lieur
EP2227243A4 (fr) Composition pharmaceutique pour traiter une maladie liée à l'obésité contenant un conjugué de peptide insulinotropique
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
MA33467B1 (fr) Promédicaments comprenant un conjugué insuline-lieur
EP1848270A4 (fr) Administration par voie transmuqueuse de compositions medicamenteuses pour le traitement et la prevention de troubles chez les animaux
PH12012501480A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MA32056B1 (fr) Suspension pharmaceutique orale contenant du paracetamol et de l'ibuprofene
ITRM20070429A1 (it) Mezzi per la diagnosi la prevenzione e la cura dell'artrite reumatoide.
Laar et al. Pain treatment in arthritis-related pain: beyond NSAIDs
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
NZ595127A (en) Stable pharmaceutical composition for atherosclerosis
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
Cantley et al. Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases
MA34670B1 (fr) Inhibiteurs de l'apoptose et leurs utilisations
EA201270071A1 (ru) Способ лечения пациента, нуждающегося в аспириновой терапии
MA29722B1 (fr) Schema posologique pour le prasugrel
GB0700027D0 (en) A combination composition
MA33602B1 (fr) Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide
MY149863A (en) Delayed-release glucocorticoid treatment of rheumatoid disease
JP2012505830A5 (fr)
EP2127673A4 (fr) Agent pharmaceutique pour la prévention et le traitement d'une maladie cutanée induite par une kératinisation accélérée
EP2307006A4 (fr) Composition pharmaceutique contenant un dérivé de 1,2-dithiolthione pour la prévention ou le traitement d une maladie causée par la surexpression de lxr-alpha
MA39448A1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
DE602006021348D1 (de) Feste form von amg 706 und pharmazeutische zusammensetzungen davon